• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈部肌张力障碍模式改变的诱发因素。

Predisposing factors to pattern change in cervical dystonia.

作者信息

Trinchillo Assunta, Cuomo Nunzia, Habetswallner Francesco, Esposito Marcello

机构信息

Neuroscience and Cell Biology Institute, Neuromodulation and Motor Control Section, St. George's University of London, London, UK.

Department of Neurosciences, Reproductive Sciences and Odontostomatology, "Federico II", University, Naples, Italy.

出版信息

J Neural Transm (Vienna). 2025 Feb;132(2):253-256. doi: 10.1007/s00702-024-02848-1. Epub 2024 Oct 14.

DOI:10.1007/s00702-024-02848-1
PMID:39402173
Abstract

BACKGROUND

Cervical dystonia (CD) patterns may change with Botulinum toxin (BoNT) treatment.

OBJECTIVE

To evaluate the time within those changes usually occur, the most predisposed phenotypes and predisposing factors.

METHODS

We divided idiopathic CD patients into two groups- change YES and NO, collecting general clinical and demographic variables. We also evaluated duration of BoNT treatment, Tsui total scores and subscores - assessed at T0 - before BoNT start - and at T1- time to chenge in the YES group or last visit in the NO group. The risk of pattern change was assessed by Kaplan Meyer curves and Cox regression analysis. Finally, Multivariate linear regressions were employed to assess if Tsui severity correlated with the change.

RESULTS

Among 100 patients (60 women), 37 experienced a phenotype switch, mostly in the first five years of BoNT treatment, YES and NO groups were comparable. Multivariate Cox Regression revealed the presence of laterocollis or rotatocollis at T0 as predictors of switch (respectively P = 0.01, HR = 3.5; P = 0.03, HR = 1.5). Multivariate linear regressions revealed that high Tsui subscores for the tilt and low Tsui total scores were risk factors for the change of pattern (respectively P = 0.002, OR = 6; P = 0.03, OR = 0.8).

CONCLUSIONS

Latero and Rotatocollis are the CD phenotypes most predisposed to change. CD characterized by neck tilt are more likely to change phenotype following treatment. Dystonias with a low degree of severity are more predisposed to switch. Both, the different degree of muscle activation and BoNT mechanism of action, may impact on that phenomenon.

摘要

背景

肉毒杆菌毒素(BoNT)治疗可能会改变颈部肌张力障碍(CD)的模式。

目的

评估这些变化通常发生的时间、最易发生变化的表型及诱发因素。

方法

我们将特发性CD患者分为两组——变化组(是)和非变化组,收集一般临床和人口统计学变量。我们还评估了BoNT治疗的持续时间、徐氏总分及分项评分——在T0(BoNT开始治疗前)和T1(变化组发生变化的时间或非变化组的最后一次就诊时间)进行评估。通过Kaplan - Meyer曲线和Cox回归分析评估模式变化的风险。最后,采用多元线性回归评估徐氏严重程度是否与变化相关。

结果

在100例患者(60名女性)中,37例出现了表型转换,大多发生在BoNT治疗的前五年,变化组和非变化组具有可比性。多变量Cox回归显示,T0时存在侧方痉挛或旋转痉挛是转换的预测因素(分别为P = 0.01,HR = 3.5;P = 0.03,HR = 1.5)。多元线性回归显示,倾斜的高徐氏分项评分和低徐氏总分是模式变化的危险因素(分别为P = 0.002,OR = 6;P = 0.03,OR = 0.8)。

结论

侧方痉挛和旋转痉挛是最易发生变化的CD表型。以颈部倾斜为特征的CD在治疗后更有可能改变表型。严重程度较低的肌张力障碍更容易发生转换。肌肉激活程度的不同和BoNT的作用机制都可能影响这一现象。

相似文献

1
Predisposing factors to pattern change in cervical dystonia.颈部肌张力障碍模式改变的诱发因素。
J Neural Transm (Vienna). 2025 Feb;132(2):253-256. doi: 10.1007/s00702-024-02848-1. Epub 2024 Oct 14.
2
Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.长期肉毒毒素治疗痉挛性斜颈患者的生活质量:一项横断面研究的结果。
Parkinsonism Relat Disord. 2018 Dec;57:63-67. doi: 10.1016/j.parkreldis.2018.07.019. Epub 2018 Jul 31.
3
The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia.初始严重程度对后期结局的影响:特发性颈肌张力障碍的大样本未经肉毒毒素治疗患者的回顾性分析。
J Neurol. 2021 Jan;268(1):206-213. doi: 10.1007/s00415-020-10128-7. Epub 2020 Aug 5.
4
Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.颈肌张力障碍:影响肉毒毒素长期治疗患者满意度的因素。
Neurol Res. 2020 Nov;42(11):987-991. doi: 10.1080/01616412.2020.1796430. Epub 2020 Jul 22.
5
An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia.A型肉毒毒素治疗颈肌张力障碍的疗效分析。
Technol Health Care. 2024;32(4):2421-2430. doi: 10.3233/THC-231182.
6
The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.肉毒毒素治疗前疾病病程对颈肌张力障碍治疗过程和长期结局的影响。
Toxins (Basel). 2021 Jul 16;13(7):493. doi: 10.3390/toxins13070493.
7
Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.初治颈肌张力障碍患者中B型与A型肉毒毒素对比:随机、双盲、非劣效性试验
Mov Disord. 2008 Mar 15;23(4):510-7. doi: 10.1002/mds.21724.
8
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.NeuroBloc(B型肉毒毒素)治疗对A型肉毒毒素耐药的颈部肌张力障碍的安全性和有效性。
Neurology. 1999 Oct 22;53(7):1431-8. doi: 10.1212/wnl.53.7.1431.
9
Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.A型肉毒毒素靶向治疗颈肌张力障碍的长期疗效。
Int J Neurosci. 2022 Oct;132(10):1026-1030. doi: 10.1080/00207454.2020.1860039. Epub 2020 Dec 17.
10
Exploring the Interplay between the Clinical and Presumed Effect of Botulinum Injections for Cervical Dystonia: A Pilot Study.探索肉毒杆菌注射治疗颈肌张力障碍的临床效果与推测效果之间的相互作用:一项初步研究。
Toxins (Basel). 2023 Sep 30;15(10):592. doi: 10.3390/toxins15100592.

本文引用的文献

1
Isolated Cervical Dystonia: Diagnosis and Classification.孤立性颈肌张力障碍:诊断与分类。
Mov Disord. 2023 Aug;38(8):1367-1378. doi: 10.1002/mds.29387. Epub 2023 Mar 29.
2
Deep and superficial cervical muscles respond differently to unstable motor skill tasks.深层和浅层颈肌对不稳定运动技能任务的反应不同。
Hum Mov Sci. 2021 Dec;80:102893. doi: 10.1016/j.humov.2021.102893. Epub 2021 Nov 9.
3
Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
A型肉毒毒素注射治疗颈部肌张力障碍患者后感觉运动网络激活的变化:一项功能磁共振成像研究
Exp Brain Res. 2018 Oct;236(10):2627-2637. doi: 10.1007/s00221-018-5322-3. Epub 2018 Jul 3.
4
Basal ganglia mechanisms in action selection, plasticity, and dystonia.基底神经节在动作选择、可塑性和肌张力障碍中的作用机制。
Eur J Paediatr Neurol. 2018 Mar;22(2):225-229. doi: 10.1016/j.ejpn.2018.01.005. Epub 2018 Jan 17.
5
Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.肉毒毒素注射减少原发性肌张力障碍患者的联想可塑性。
Mov Disord. 2011 Jun;26(7):1282-9. doi: 10.1002/mds.23681. Epub 2011 Apr 5.
6
Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients.长期接受肉毒毒素治疗的患者颈部肌张力障碍模式的临床变化。
Parkinsonism Relat Disord. 2010 Jan;16(1):8-11. doi: 10.1016/j.parkreldis.2009.06.004. Epub 2009 Jul 8.
7
Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.肉毒杆菌毒素治疗颈部肌张力障碍中临床评定量表的比较
Mov Disord. 1997 Jan;12(1):100-2. doi: 10.1002/mds.870120117.
8
Double-blind study of botulinum toxin in spasmodic torticollis.肉毒杆菌毒素治疗痉挛性斜颈的双盲研究。
Lancet. 1986 Aug 2;2(8501):245-7. doi: 10.1016/s0140-6736(86)92070-2.